Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...
The 38-date run will feature a large slate of openers, including St. Vincent, Nathaniel Rateliff, and more. The Lumineers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback